Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials

This publication has 39 references indexed in Scilit:

• Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years
  Annals of Allergy, Asthma & Immunology, 2005
• Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms
  Allergy, 2004
• Efficacy and safety of sublingual immunotherapy
  Annals of Allergy, Asthma & Immunology, 2004
• Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double‐blind placebo‐controlled study
  Allergy, 2004
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Efficacy of sublingual immunotherapy in children with asthma and rhinitis: A double‐blind, placebo‐controlled study
  Pediatric Pulmonology, 2001
• Hepatitis B Immunization Coverage Among Vietnamese-American Children 3 to 18 Years Old
  Pediatrics, 2000
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement
  JAMA, 1996
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986